Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247463 | SCV000311534 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000247463 | SCV000512975 | benign | not specified | 2015-09-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000554418 | SCV000652840 | benign | Combined oxidative phosphorylation defect type 14 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Wong Mito Lab, |
RCV000554418 | SCV000845670 | benign | Combined oxidative phosphorylation defect type 14 | 2018-06-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003422171 | SCV004160252 | benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | FARS2: BP4, BP7, BS1, BS2 |
ARUP Laboratories, |
RCV003422171 | SCV005875742 | benign | not provided | 2023-12-22 | criteria provided, single submitter | clinical testing |